Article Details
Retrieved on: 2025-05-05 21:33:24
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
PCSK9 inhibitors (e.g., evolocumab and alirocumab): These monoclonal antibodies bind to and inhibit PCSK9, preventing LDL receptor degradation.
Article found on: www.pharmacytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here